Localised delivery of appropriate biomolecule/drug(s) can be suitable to prevent postoperative infections and inflammation after scaffold implantation in vivo. In this study composite shell scaffolds, based on an internally produced bioactive glass and a commercial hydroxyapatite, were surface coated with a uniform polymeric layer, embedded with thermo-stable polyesterurethane (PU)-based nanoparticles (NPs), containing an anti-inflammatory drug (indomethacin; IDCM). The obtained functionalised scaffolds were subjected to physico-mechanical and biological characterisations. The results indicated that NPs incorporation into the gelatin coating of the composite scaffolds: 1) not changed significantly the micro-architecture of the scaffolds in terms of mean pore diameter and pore size distribution; 2) increased the compressive modulus; and 3) allowed to a sustained IDMC release (65-70% of the loaded-drug) within the first week of incubation in physiological solution. On the other hand, the NPs incorporation did not affect the biocompatibility of composite scaffolds, as evidenced by viability and alkaline phosphatase (ALP) activity of MG63 human osteoblast-like cells.

Composite scaffolds for controlled drug release: role of the polyurethane nanoparticles on the physical properties and cell behaviour / Gentile, Piergiorgio; Bellucci, Devis; Sola, Antonella; Mattu, Clara; Cannillo, Valeria; Ciardelli, Gianluca. - In: JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS. - ISSN 1751-6161. - 44:(2015), pp. 53-60. [10.1016/j.jmbbm.2014.12.017]

Composite scaffolds for controlled drug release: role of the polyurethane nanoparticles on the physical properties and cell behaviour

BELLUCCI, Devis;SOLA, Antonella;CANNILLO, Valeria;
2015

Abstract

Localised delivery of appropriate biomolecule/drug(s) can be suitable to prevent postoperative infections and inflammation after scaffold implantation in vivo. In this study composite shell scaffolds, based on an internally produced bioactive glass and a commercial hydroxyapatite, were surface coated with a uniform polymeric layer, embedded with thermo-stable polyesterurethane (PU)-based nanoparticles (NPs), containing an anti-inflammatory drug (indomethacin; IDCM). The obtained functionalised scaffolds were subjected to physico-mechanical and biological characterisations. The results indicated that NPs incorporation into the gelatin coating of the composite scaffolds: 1) not changed significantly the micro-architecture of the scaffolds in terms of mean pore diameter and pore size distribution; 2) increased the compressive modulus; and 3) allowed to a sustained IDMC release (65-70% of the loaded-drug) within the first week of incubation in physiological solution. On the other hand, the NPs incorporation did not affect the biocompatibility of composite scaffolds, as evidenced by viability and alkaline phosphatase (ALP) activity of MG63 human osteoblast-like cells.
24-dic-2014
44
53
60
Composite scaffolds for controlled drug release: role of the polyurethane nanoparticles on the physical properties and cell behaviour / Gentile, Piergiorgio; Bellucci, Devis; Sola, Antonella; Mattu, Clara; Cannillo, Valeria; Ciardelli, Gianluca. - In: JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS. - ISSN 1751-6161. - 44:(2015), pp. 53-60. [10.1016/j.jmbbm.2014.12.017]
Gentile, Piergiorgio; Bellucci, Devis; Sola, Antonella; Mattu, Clara; Cannillo, Valeria; Ciardelli, Gianluca
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1751616114003968-main (1).pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 904.07 kB
Formato Adobe PDF
904.07 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
POST_PRINTj.jmbbm.2014.12.017.pdf

accesso aperto

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 874.88 kB
Formato Adobe PDF
874.88 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1073133
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 35
social impact